{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:10:15Z","timestamp":1791277815758,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.2146\/ajhp120055","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T18:39:42Z","timestamp":1348166382000},"page":"1646-1650","source":"Crossref","is-referenced-by-count":56,"title":["Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma"],"prefix":"10.1093","volume":"69","author":[{"given":"Lisa E.","family":"Dumkow","sequence":"first","affiliation":[{"name":"Henry Ford Hospital (HFH), Detroit, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan R.","family":"Voss","sequence":"additional","affiliation":[{"name":"Wayne State University\/HFH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, HFH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Jennings","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital (HFH), Detroit, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041204012125800_b1-0691646","volume-title":"Pradaxa (dabigatran etexilate) package insert","year":"2012"},{"key":"2019041204012125800_b2-0691646","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA."},{"issue":"(suppl)","key":"2019041204012125800_b3-0691646","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest."},{"key":"2019041204012125800_b4-0691646","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIR.0b013e31820f14c0","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation."},{"key":"2019041204012125800_b5-0691646","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.emc.2011.01.003","article-title":"Gastrointestinal bleeding","volume":"29","author":"Kumar","year":"2011","journal-title":"Emerg Med Clin N Am."},{"key":"2019041204012125800_b6-0691646","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MCG.0b013e31818f9227","article-title":"Gastrointestinal side effects of prescription medications in the older adult","volume":"43","author":"Jain","year":"2009","journal-title":"J Clin Gastroenterol."},{"key":"2019041204012125800_b7-0691646","unstructured":"Zhao\n              Y\n            \n            \n              Encinosa\n              W\n            \n          . Statistical brief #65: hospitalizations for gastrointestinal bleeding in 1998 and 2006. www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb65.jsp (accessed 2012 Jun 18)."},{"key":"2019041204012125800_b8-0691646","unstructured":"Food and Drug Administration. FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2010\/ucm230241.htm?utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=Dabigatran%20Etexilate&utm_content=18 (accessed 2012 Jun 14)."},{"key":"2019041204012125800_b9-0691646","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"2019041204012125800_b10-0691646","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/STROKEAHA.111.624650","article-title":"Hemostatic therapy in experimental in-tracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran","volume":"42","author":"Zhou","year":"2011","journal-title":"Stroke."},{"key":"2019041204012125800_b11-0691646","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinternmed.2011.314","article-title":"The use of dabigatran in elderly patients","volume":"171","author":"Legrand","year":"2011","journal-title":"Arch Intern Med."},{"key":"2019041204012125800_b12-0691646","unstructured":"European Medicines Agency. European Medicines Agency updates on safety of Pradaxa. www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2011\/11\/WC500117818.pdf (accessed 2012 Jun 18)."},{"key":"2019041204012125800_b13-0691646","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron."},{"key":"2019041204012125800_b14-0691646","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1537-2995.2008.02080.x","article-title":"Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose","volume":"49","author":"Holland","year":"2009","journal-title":"Transfusion."},{"key":"2019041204012125800_b15-0691646","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1345\/aph.1Q288","article-title":"Using prothrombin complex concentrates to rapidly reverse oral anticoagulants","volume":"45","author":"Dager","year":"2011","journal-title":"Ann Pharmacother."},{"key":"2019041204012125800_b16-0691646","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation."},{"key":"2019041204012125800_b17-0691646","volume-title":"Profilnine SD (factor IX complex) package insert","year":"2004"},{"key":"2019041204012125800_b18-0691646","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2014a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"Van Ryn","year":"2010","journal-title":"Thromb Haemost."},{"key":"2019041204012125800_b19-0691646","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000081505","article-title":"The ecarin clotting time, a universal method to quantify direct thrombin inhibitors","volume":"33","author":"Nowak","year":"2004","journal-title":"Pathophysiol Haemost Thromb."},{"key":"2019041204012125800_b20-0691646","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000081506","article-title":"Ecarin chromogenic assay\u2014a new method for quantitative determination of direct thrombin inhibitors like hirudin","volume":"33","author":"Lange","year":"2004","journal-title":"Pathophysiol Haemost Thromb."},{"key":"2019041204012125800_b21-0691646","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate\u2014an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet."},{"key":"2019041204012125800_b22-0691646","unstructured":"Boehringer Ingelheim. Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa (dabigatran etexilate) in Europe. www.boehringer-ingelheim.com\/news\/news_releases\/press_releases\/2011\/27_october_2011_dabigatran.html (accessed 2012 Mar 5)."},{"key":"2019041204012125800_b23-0691646","unstructured":"O\u2019Riordan\n              M\n            \n          . U.S. dabigatran label updated, including renal-function recommendations. www.theheart.org\/article\/1306579.do?utm_campaign=newsletter&utm_medium=email&utm_source=20111110_EN_Heartwire (accessed 2011 Nov 13)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/19\/1646\/28361963\/ajhp1646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:03:16Z","timestamp":1555113796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/19\/1646\/5112011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":23,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp120055","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,10,1]]},"published":{"date-parts":[[2012,10,1]]}}}